Business Wire

GLOBAL-DAIRY-PLATFORM

11.11.2022 01:02:43 CET | Business Wire | Press release

Share
Dairy Sector Reports Progress on Global Pathways to Dairy Net Zero Climate Initiative at COP27

The dairy sector today announced progress of its global Pathways to Dairy Net Zero (P2DNZ) climate initiative, which was launched last year. The ground-breaking effort is achieving positive results in many regions and accelerating action in others, according to speakers at a COP27 side event, “The Global Dairy Sector’s Climate Ambition and Progress Towards Achievement of the Paris Agreement.”

P2DNZ is backed by more than 140 leading organizations and governments, including the 10 largest dairy companies in the world. Collectively, supporters represent more than 40% of global dairy production throughout the supply chain, making it one of the largest initiatives of its kind in agriculture.

“Dairy is a major force for good in the world, especially when you consider how the sector helps provide important nutrition to the hungry and malnourished and helps build strong, resilient economies, said Hein Schumacher, chair of Global Dairy Platform, one of the founders of Pathways to Dairy Net Zero, and CEO of Royal FrieslandCampina. “By systematically introducing and enhancing climate action in global dairy systems, dairy is tackling the challenge and making progress in reducing our impact on the planet,” he said.

Research is Identifying Practical Pathways for Dairy Systems Worldwide
Research commissioned as part of P2DNZ has identified six primary dairy production systems throughout the world, along with potential mitigation options and their estimated impact on emissions reduction. The research is led by the Global Research Alliance on Agricultural Greenhouse Gases (GRA) in close collaboration with the UN Food and Agriculture Organization (FAO). They have defined the composition of GHGs emitted by the various dairy production systems around the world and learned there is variability by system. For instance, methane is a large proportion of GHGs in pastoral and agropastoral systems, driven largely by enteric fermentation. However, high-input, high-output production emits a different mix of GHGs from not only enteric fermentation but also manure management, animal feed and energy use.

The six dairy production systems include:

  • High-input, high-output
  • Medium-scale specialized
  • Pasture-fed
  • Smallholder specialized
  • Smallholder dual-purpose
  • Pastoral and agropastoral

Researchers are also modeling the impact on warming of cumulative emissions for each GHG. This work is critical because each gas has a different effect and unique longevity in the atmosphere. For instance, while methane is a highly potent GHG it breaks down in the atmosphere in 12 years. Whereas other gases, such as carbon dioxide, can remain in the atmosphere for hundreds of years.

Although mitigation options will vary by each dairy production system, some of the primary pathways include improving animal health, increasing feed digestibility, enhanced manure storage and treatment, more efficient fertilizer use and the potential adoption of methane-inhibiting feed additives.

“Because GRA brings together leading expertise in agricultural GHG emissions, we are pleased to be working on the Pathways to Dairy Net Zero initiative to map emissions and mitigation potential within the diverse range of global dairy production systems,” said Dr. Harry Clark, co-chair of the Livestock Research Group of GRA and co-director of the New Zealand Agricultural Greenhouse Gas Research Centre. “While there are good options emerging for dairy systems in developed countries, our analysis reinforces the importance of developing and implementing appropriate options for regions and systems where the climate, soil and access to markets have limited options,” he said.

Progress in Developed Markets
Dairy companies around the world are reducing their impacts on the environment by improving farming and production practices and developing new technologies. FAO reports that during the period from 2005 – 2015, the global dairy sector’s emission intensity declined by 11%. Dairy farming has become more efficient which is resulting in declining emission intensities per unit of product all over the world. This is especially true in developed dairy markets where emission intensities have declined to between 1.3 to 1.4 kg CO₂ equivalent kg fat-and-protein corrected milk. For comparison, developing dairy regions’ emission intensities can range between 4.1 to 6.7 kg CO₂ equivalent per kg fat-and-protein corrected milk.

Tackling Emissions in Emerging Markets
Many of the best practices that have already been developed are being implemented in emerging dairy countries, where approximately 80% of the global dairy sector’s emissions are generated.

To help facilitate and accelerate these efforts, the global dairy sector, the Global Methane Pledge, FAO and others have invited 10 developing dairy countries to join P2DNZ as “early adopters.” Collectively these countries represent more than 30% of the sector’s global GHG emissions and include (those in bold have already accepted):

  • Africa: Tanzania, Kenya, Rwanda, Uganda
  • Americas: Uruguay, Costa Rica, Colombia
  • Asia: Pakistan, Vietnam, India

For more information, or to join Pathways to Dairy Net Zero, visit: www.pathwaystodairynetzero.org.

###

About Pathways to Dairy Net Zero
Pathways to Dairy Net Zero is a vibrant, growing movement, the first of its kind in the world. It brings together dairy systems of every size and type, including organizations throughout the dairy supply chain.

Partners include: Global Dairy Platform, International Dairy Federation, Sustainable Agriculture Initiative Platform, International Livestock Research Institute, Dairy Sustainability Framework and IFCN Dairy Research Network.

The Global Research Alliance on Agricultural Greenhouse Gases is a knowledge partner.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005906/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye